{"anticipatedPostingDate":"2027-05","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"From randomization up to 30 days after last dose of study treatment or disease progression or initiation of subsequent therapy, whichever occurs first (up to 3 years)","title":"Response Rates by International Myeloma Working Group (IMWG) 2016 Criteria","type":"SECONDARY"}